210 related articles for article (PubMed ID: 32481259)
21. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance.
Mariot V; Maupetit-Méhouas S; Sinding C; Kottler ML; Linglart A
J Clin Endocrinol Metab; 2008 Mar; 93(3):661-5. PubMed ID: 18182455
[TBL] [Abstract][Full Text] [Related]
22. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
[TBL] [Abstract][Full Text] [Related]
23. Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs{alpha} coding mutations and GNAS imprinting defects.
Lecumberri B; Fernández-Rebollo E; Sentchordi L; Saavedra P; Bernal-Chico A; Pallardo LF; Bustos JM; Castaño L; de Santiago M; Hiort O; Pérez de Nanclares G; Bastepe M
J Med Genet; 2010 Apr; 47(4):276-80. PubMed ID: 19858129
[TBL] [Abstract][Full Text] [Related]
24. The GNAS locus and pseudohypoparathyroidism.
Bastepe M
Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
[TBL] [Abstract][Full Text] [Related]
25. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
Mantovani G; Elli FM; Spada A
Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
[TBL] [Abstract][Full Text] [Related]
26. Clinical characterization and identification of two novel mutations of the GNAS gene in patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism.
Jin HY; Lee BH; Choi JH; Kim GH; Kim JK; Lee JH; Yu J; Yoo JH; Ko CW; Lim HH; Chung HR; Yoo HW
Clin Endocrinol (Oxf); 2011 Aug; 75(2):207-13. PubMed ID: 21521295
[TBL] [Abstract][Full Text] [Related]
27. [Different expression of the Asn264LysfsX35 mutation of the GNAS gene in a family with pseudohypoparathyroidism.].
de Arriba Muñoz A; Labarta Aizpún JI; Dehesa EM; Calvo MT; Pérez de Nanclares G; Ferrández-Longás A
An Pediatr (Barc); 2011 Feb; 74(2):116-21. PubMed ID: 21169072
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
[TBL] [Abstract][Full Text] [Related]
29. Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications.
Mazoni L; Apicella M; Saponaro F; Mantovani G; Elli FM; Borsari S; Pardi E; Piaggi P; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3005-e3020. PubMed ID: 33780542
[TBL] [Abstract][Full Text] [Related]
30. Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B.
Fernandez-Rebollo E; García-Cuartero B; Garin I; Largo C; Martínez F; Garcia-Lacalle C; Castaño L; Bastepe M; Pérez de Nanclares G
J Clin Endocrinol Metab; 2010 Feb; 95(2):765-71. PubMed ID: 20008020
[TBL] [Abstract][Full Text] [Related]
31. A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature.
Brancatella A; Mantovani G; Elli FM; Borsari S; Marcocci C; Cetani F
Endocrine; 2020 Feb; 67(2):466-472. PubMed ID: 31939093
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.
Laspa E; Bastepe M; Jüppner H; Tsatsoulis A
J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741
[TBL] [Abstract][Full Text] [Related]
33. Pseudohypoparathyroidism type Ib in 2015.
Mantovani G; Elli FM
Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998
[TBL] [Abstract][Full Text] [Related]
34. Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.
Turan S; Thiele S; Tafaj O; Brix B; Atay Z; Abali S; Haliloglu B; Bereket A; Bastepe M
Bone; 2015 Feb; 71():53-7. PubMed ID: 25464124
[TBL] [Abstract][Full Text] [Related]
35. Clinical, biochemical, and genetic analysis of korean patients with pseudohypoparathyroidism type Ia.
Park CH; Park HD; Lee SY; Kim JW; Sohn YB; Park SW; Jin DK
Ann Clin Lab Sci; 2010; 40(3):261-6. PubMed ID: 20689139
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib.
Mantovani G; Bondioni S; Linglart A; Maghnie M; Cisternino M; Corbetta S; Lania AG; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2007 Sep; 92(9):3738-42. PubMed ID: 17595244
[TBL] [Abstract][Full Text] [Related]
37. Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption.
de Sanctis L; Giachero F; Mantovani G; Weber G; Salerno M; Baroncelli GI; Elli MF; Matarazzo P; Wasniewska M; Mazzanti L; Scirè G; Tessaris D;
Ital J Pediatr; 2016 Nov; 42(1):101. PubMed ID: 27871293
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.
Long XD; Xiong J; Mo ZH; Dong CS; Jin P
BMC Med Genet; 2018 Jul; 19(1):132. PubMed ID: 30060753
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.
de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M
J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843
[TBL] [Abstract][Full Text] [Related]
40. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G
J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
